Dextrose 20% Injection USP
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| Lot 21105JT | Dextrose 20% Injection USP | - Recalling Firm
- Hospira Healthcare Corporation Suite 600 - 1111 Dr. Frederik Philips Blvd, Saint-Laurent, Quebec H4M 1X6
- Marketing Authorization Holder
- Hospira Healthcare Corporation Suite 600 - 1111 Dr. Frederik Philips Blvd, Saint-Laurent, Quebec H4M 1X6
| Solution | DIN 00037966 | 200 mg/mL |
Recalled Products
Dextrose 20% Injection USP
Lot# 21105JT is recalled as sampling results did not meet the Acceptable Quality Level (AQL) for primary bag leaks during visual inspection.
Wholesalers and hospitals in Canada.